why choose us

300×250 Ad Slot

Research Article: Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience

Date Published: 2023-06-09

Introduction:
Hepatocellular carcinoma (HCC) is the sixth-most common neoplasm and the third leading cause of cancer-related death. HCC has been recognized as a leading cause of death among patients with cirrhosis. Hepatitis B virus (HBV) infection is one of the major causes of HCC. In addition to alcohol, hepatitis C virus (HCV) and aflatoxin B, which are driven by a combination of genetic susceptibility, lifestyle, environmental factors, and HBV virus infection, can also contribute to the development of HCC.

Read more

300×250 Ad Slot